Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice

NYL Pang, ASR Pang, VT Chow, DY Wang - Military Medical Research, 2021 - Springer
SARS-CoV-2 is a newly identified member of the coronavirus family that has caused the
Coronavirus disease 2019 (COVID-19) pandemic. This rapidly evolving and unrelenting …

Immunity to SARS‐CoV‐2 induced by infection or vaccination

X Castro Dopico, S Ols, K Loré… - Journal of internal …, 2022 - Wiley Online Library
Adaptive immune responses play critical roles in viral clearance and protection against re‐
infection, and SARS‐CoV‐2 is no exception. What is exceptional is the rapid …

Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study

M Augustin, P Schommers, M Stecher… - The Lancet Regional …, 2021 - thelancet.com
Background While the leading symptoms during coronavirus disease 2019 (COVID-19) are
acute and the majority of patients fully recover, a significant fraction of patients now …

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo …

C Chaccour, A Casellas, A Blanco-Di Matteo… - …, 2021 - thelancet.com
Background Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not
readily achievable with currently approved doses. There is limited evidence to support its …

Evaluation and comparison of serological methods for COVID-19 diagnosis

F Gong, H Wei, Q Li, L Liu, B Li - Frontiers in Molecular Biosciences, 2021 - frontiersin.org
The worldwide pandemic of COVID-19 has become a global public health crisis. Various
clinical diagnosis methods have been developed to distinguish COVID-19–infected patients …

Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses

EJ Needham, AL Ren, RJ Digby, EJ Norton, S Ebrahimi… - Brain, 2022 - academic.oup.com
COVID-19 is associated with neurological complications including stroke, delirium and
encephalitis. Furthermore, a post-viral syndrome dominated by neuropsychiatric symptoms …

COVID-19 antibody tests: a valuable public health tool with limited relevance to individuals

R West, A Kobokovich, N Connell, GK Gronvall - Trends in microbiology, 2021 - cell.com
Antibody tests for detecting past infection with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) have many uses for public health decision making, but …

The importance of understanding the stages of COVID-19 in treatment and trials.

DO Griffin, D Brennan-Rieder, B Ngo, P Kory… - AIDS …, 2021 - search.ebscohost.com
Abstract COVID-19, caused by SARS-CoV-2, continues to be a major health problem since
its first description in Wuhan, China, in December 2019. Multiple drugs have been tried to …

[HTML][HTML] Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

J Wei, PC Matthews, N Stoesser, T Maddox… - Nature …, 2021 - nature.com
Understanding the trajectory, duration, and determinants of antibody responses after SARS-
CoV-2 infection can inform subsequent protection and risk of reinfection, however large …

Gold-nanostar-chitosan-mediated delivery of SARS-CoV-2 DNA vaccine for respiratory mucosal immunization: development and proof-of-principle

US Kumar, R Afjei, K Ferrara, TF Massoud… - ACS …, 2021 - ACS Publications
The COVID-19 pandemic is caused by the coronavirus SARS-CoV-2 (SC2). A variety of anti-
SC2 vaccines have been approved for human applications, including those using …